Expert says sunscreen users shouldn't be deterred
Despite a recent study which concluded that sunscreen enters the bloodstream after just one day of use, experts are urging the public to continue using sunscreen.
Latest News
23 food, dietary supplement recalls initiated
Food producers carried out 23 food or dietary supplement product recalls over the past month, according to the U.S. Food and Drug Administration.
FDA strengthens warning for prescription insomnia medicines
The U.S. Food and Drug Administration is now requiring its strongest warning to be used on several of the most commonly used prescription insomnia medicines.
Man who beat Lou Gehrig’s disease points to need for 'Right to Try' laws
A McDonough, Georgia man who was the first to fight of a debilitating and deadly disease points out the reasons why “right to try” legislation that is being considered in North Carolina needs to succeed, according to a Washington Post op-ed piece.
7 drugs recalled during April, FDA reports
Seven drugs were recalled in April to protect patients from possible harmful defects associated with the products, the U.S. Food and Drug Administration reported.
Approval of device to treat ADHD welcomed, with some caution
Parents, doctors and other stakeholders are welcoming the approval of a device to help treat children of a certain age with attention-deficit/hyperactivity disorder (ADHD), but with caution.
Clinical drug trial costs 'surprisingly low,' Johns Hopkins researchers find
Contrary to past drug company pronouncements, the cost of clinical trials makes up a small fraction of pharmaceutical drug development costs, a new study concludes.
'Stop doing these analyses,' Mercatus Center researcher says ahead of FDA benefit-risk public meeting
The U.S. Food and Drug administration's public meeting in May about the agency's human drug lifecycle benefit-risk activities has already attracted a recommendation from a regulatory and policy researcher: “stop doing these analyses.”
Out-of-pocket drug costs a key voter concern, new poll finds
Lowering out-of-pocket costs for prescription drugs is among American voters’ top health concerns, a new poll by released by a drug company trade association concludes.
FDA drug approvals lag as other countries speed up process
Getting pharmaceutical drugs to market for treatment of diseases and conditions as quickly as possible has been a challenge for the U.S. Food and Drug Administration, even as other countries have sped up the process in favor of making new prescription drugs available to people sooner.
20 food, dietary supplement recalls initiated
Food producers carried out 20 food or dietary supplement product recalls over the past two months, according to the U.S. Food and Drug Administration.
Duke University's McClellan cites FDA improvements
The FDA has made significant strides in drug safety reform over the past decade, says a leading authority from Duke University.
FDA Update: March medical device recalls
Recalls of medical devices occur when a company sees a need to either take corrective action or remove a potentially hazardous device from the market, according to the U.S. Food and Drug Administration.
11 drugs recalled during March, FDA reports
Eleven drugs were recalled in March to protect patients from possible harmful defects associated with the products, the U.S. Food and Drug Administration reported.
12 drugs recalled in first 60 days of 2019, FDA reports
Twelve prescription drugs were recalled in January and February to protect patients from possible harmful defects associated with the products, the U.S. Food and Drug Administration reported.
FDA approves quicker Strep A test
A global company has had its third test cleared by the U.S. Food and Drug Administration which this month approved GenePOC’s Strep A assay, which provides in vitro diagnosis of Strep A infections within an hour.
FDA approves Optimizer Smart System for heart patients
The U.S. Food and Drug Administration estimates that nearly 6 million Americans have heart failure — the organ can’t keep up with their bodies’ needs.
FDA seeks to modernize protocols in response to 'precision medicine'
Getting effective treatments for diseases and conditions to people as quickly as possible while guaranteeing their safety and efficacy, as well as protecting the safety of trial subjects, has always been a delicate balancing act for the U.S. Food and Drug Administration (FDA), the federal agency responsible for the safety of pharmaceuticals and medical devices, among other things.
FDA Update: January-February medical device recalls
Recalls of medical devices occur when a company sees a need to either take corrective action or remove a potentially hazardous device from the market, according to the Food and Drug Administration.
.jpg)
FDA issues warning of possible medical device shortage following shutdown of Sterigenics plant
FDA is warning of the possibility of a shortage of sterilized medical devices, possibly posing a threat to public health.